Cerenome (CNSY) EBITDA (2011 - 2026)
Analysis
Cerenome (CNSY) EBITDA (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | -815.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | -505.13 Mn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 325.05 Mn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 231.44 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 133.12 Mn |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | -9.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.06 Mn |
| Mar 31, 2026 | -7.12 Mn |
| Dec 31, 2025 | -5.74 Mn |
| Sep 30, 2025 | -4.48 Mn |
| Jun 30, 2025 | -1.54 Mn |
| Mar 31, 2025 | -3.54 Mn |
| Dec 31, 2024 | -3.90 Mn |
| Sep 30, 2024 | -3.80 Mn |
| Jun 30, 2024 | -3.70 Mn |
| Mar 31, 2024 | -3.30 Mn |
| Dec 31, 2023 | -3.86 Mn |
| Sep 30, 2023 | -3.25 Mn |
| Jun 30, 2023 | -1.49 Mn |
| Mar 31, 2023 | -4.72 Mn |
| Dec 31, 2022 | -5.57 Mn |
| Sep 30, 2022 | -5.09 Mn |
| Jun 30, 2022 | -5.12 Mn |
| Mar 31, 2022 | -3.93 Mn |
| Dec 31, 2021 | -3.94 Mn |
| Sep 30, 2021 | -3.50 Mn |